Independent Allocation of Vaccines Group (IAVG)
The main purpose of the IAVG is to perform regular reviews of COVAX allocations against principle and objectives of Phase 2 Allocations and provide strategic guidance to WHO and COVAX partners on potential areas for improvement and on policy decisions relating to the allocation COVID-19.
Members
Professor Tjandra Yoga Aditama
Director, Post Graduate School, YARSI University Jakarta Indonesia
Prof Narendra Kumar Arora
Executive Director of The INCLEN Trust International, India
Dr Manica Balasegaram
Executive Director, Global Antibiotic Research & Development Partnership (GARDP)
Dr Alejandro Cravioto
Professor, Faculty of Medicine of the National Autonomous University of Mexico (UNAM) in Mexico City
Dr Bruce G. Gellin
President, Global Immunization Sabin Vaccine Institute
Dr Maria Guevara
Medical Secretary, MSF International
Dr Masahiko Hachiya
Director, Division of Global Health Policy and Research, National Center for Global Health and Medicine (NCGM), Japan
Dr Arlene King
Consultant in public health and preventive medicine and Adjunct Professor at the Dalla Lana School of Public Health at the University of Toronto, Toronto, Canada. (IAVG Co-Chair)